Literature DB >> 7712680

Iterative pulse administration of succinic acid monomethyl ester to streptozotocin diabetic rats.

A G Akkan1, W J Malaisse.   

Abstract

In adult rats injected intravenously with streptozotocin (STZ: 20 or 40 mg/kg body wt) and examined 13 days later, the secretory response of the perfused pancreas to D-glucose is impaired. A paradoxical inhibition of insulin release is even observed in the perfused pancreas of rats given the high STZ dose. When pulses of succinate monomethyl ester (SAM: 60 mg) were administered intraperitoneally three times a day for one week from the 6th to 12th day after STZ injection, no obvious difference in insulin output from the perfused pancreas stimulated with either D-glucose or SAM was observed between SAM-treated and untreated rats first injected with the low STZ dose. However, in rats first injected with the high STZ dose, the secretory response to SAM was higher in SAM-treated than untreated animals. These findings raise the view that suitable non-glucidic nutrient secretagogues might improve, in a long term manner, the secretory potential of the endocrine pancreas in animal models of diabetes characterized by a preferential impairment of the B-cell response to D-glucose.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7712680

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  3 in total

1.  Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin.

Authors:  D Vicent; M L Villanueva-Peñacarrillo; I Valverde; W J Malaisse
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

Review 2.  The beta cell in NIDDM: giving light to the blind.

Authors:  W J Malaisse
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Effect of repaglinide on insulin secretion in islets from rats infused for two days with a hypertonic solution of D-glucose.

Authors:  K Louchami; L Ladrière; H Jijakli; W J Malaisse
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.